Skip to content

Clinical study on infertility caused by premature ovarian insufficiency treated with mili-fire needle syndrome differentiation

Clinical study on infertility caused by premature ovarian insufficiency treated with mili-fire needle syndrome differentiation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047655
Enrollment
Unknown
Registered
2021-06-21
Start date
2021-06-21
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ovarian insufficiency

Interventions

Sponsors

Nanjing Hospital of Traditional Chinese Medicine Affiliated Hospital of Nanjing University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
24 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. According to the diagnosis of infertility caused by early ovarian function in western medicine and the syndrome differentiation of traditional Chinese medicine, patients with kidney deficiency; 2. Women aged 24 to 40 years; 3. Men with normal reproductive function; 4. Anti-muller hormone AMH 1.1 to 2ng/ml; 5. The number of sinus follicles AFC < 4; 6. Agreed to receive treatment according to this program and follow up observers; 7. Willing to sign informed consent; 8. Willing to register a case.

Exclusion criteria

Exclusion criteria: 1. Women in pregnancy or menopause at the time of consultation; 2. Organic lesions causing POI were confirmed by conventional gynecological examinations, such as imaging examination and secretion examination; 3. Have received the relevant treatment and may affect the effect observation indicators; 4. Severe heart, liver and kidney injuries affect normal drug metabolism; 5. The combination of other physiological or pathological states that may affect the effect indicators; 6. Withdrawal from treatment due to personal reasons; 7. Failure to strictly implement the intervention measures and change the treatment plan leads to failure to collect or produce errors in relevant data such as feedback of efficacy and effect indicators; 8. Severe adverse reactions and complications occur during treatment, and they are unable to continue treatment; 9. Use of drugs that interfere with the treatment plan; 10. Participate other experimenters at the same time; 11. Unable to complete the filling of various scales; 12. Unwilling to be randomly grouped; 13. Patients with abnormal thyroid function.

Design outcomes

Primary

MeasureTime frame
sex hormone;B ultrasound imaging monitoring and evaluation;Oxidative stress index;

Secondary

MeasureTime frame
The pregnancy rate;Clinical Correlation Scale;

Countries

China

Contacts

Public ContactZhang Cairong

Nanjing Hospital of Traditional Chinese Medicine

njszyyzcr@163.com+86 18951755167

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026